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Abstract The purpose of the present study was to explore
factors that influence the occurrence of the Babinski sign
(BS) in complete spinal cord injury patients. At Balgrist
University Hospital, Zurich, Switzerland, thirty-five sub-
jects suffering from a complete traumatic spinal cord injury
(ASIA A) were examined for the occurrence of the BS,
tendon reflex excitability and spastic muscle tone (Modi-
fied Ashworth Scale). Five subjects were acute/subacute
(1–6 months after spinal cord injury (SCI)), 30 were
chronic (SCI [ 1 year). In one subject, the measures
were examined before and after injection of intrathecal
Baclofen. Subjects with a negative BS were investigated
electrophysiologically for possible peripheral nerve dam-
age. In 17 subjects (49%), the BS was present, while it was
absent in 18 subjects (51%). The occurrence of the BS did
not depend on the level of lesion. Most patients with a
positive BS also presented a high spastic muscle tone,
while those with a negative BS showed low level or absent
spastic muscle tone. In 11 SCI subjects, absence of the
BS was associated with peripheral nerve damage. In one
patient, the BS along with spastic signs disappeared after
intrathecal injection of Baclofen. In complete SCI subjects,
the occurrence of the BS is connected with spastic muscle
tone. The absence of the BS is frequently due to associated
peripheral nerve damage.
Keywords Babinski sign  Reflex excitability 
Spinal cord injury  Spasticity  Baclofen
Introduction
The Babinski sign (BS) was first described in 1896 [2]. It
has been widely used in clinical neurology as a diagnostic
sign indicating a pyramidal lesion. However, its patho-
physiology has been a matter of debate, and it remains
unclear whether its occurrence solely depends on the
presence of a pyramidal lesion. The BS is thought to be
part of the general withdrawal reflex synergy released by a
lesion of supraspinal pathways that project onto the inter-
neuronal zone of the lumbosacral cord [18]. At the same
time, its presence also requires a lesion or functional deficit
of those fibres projecting directly onto the motoneurons of
the effector muscles [8, 13]. The effector organ of the
reflex is the extensor hallucis longus (EHL) [8].
In pyramidal tract syndrome, only impairment of skilled
foot movements is closely connected with occurrence of
the BS. Therefore the latter is assumed to indicate a dis-
turbance of the closely related pyramidal tract fibres [18].
If the BS is absent in the case of an upper motor neuron
lesion this is thought to be due to a dysfunction of the
segmental reflex pathways, normally caused by a pressure
palsy of the peroneal nerve, or by an inexcitability of spinal
motoneurons due to spinal shock [19].
Babinski himself assumed that a dysfunction of the
pyramidal system is necessary but not sufficient to produce
a BS [1]. Conversely, some post-mortem examinations
have shown that an absence of the BS is compatible with
severe lesions of the cortico-spinal tract and that in some
cases the cortico-spinal tract appears to be intact while the
BS is positive [17]. The conclusion from these studies
would be that there is no particular relationship between
the anatomical state of the cortico-spinal tracts and the
appearance of the BS. In fact, our empirical impression
from regular clinical examinations of complete tetra- and
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paraplegic patients was that not all patients had a positive
BS.
The aim of this study was to quantify this observation
and to delineate factors that influence the inconsistent
occurrence of the BS in complete spinal cord injury (SCI)
after spinal shock has resolved.
Patients and methods
All subjects included in the study provided informed con-
sent before participation. Ethical approval for the study was
obtained from the local research ethics committee. The
investigations were made in 10 tetraplegic and 25 para-
plegic patients (five women and thirty men). The patients’
ages ranged from 19 to 85 years (mean 45 years). All
patients had sensory and motor complete (ASIA A) trau-
matic SCI according to the American Spinal Injury Asso-
ciation Impairment Scale. Levels of lesion were from C4 to
T12. Subjects with conus, cauda and lumbar lesions were
excluded. The time between the initial trauma and the date
of examination was between four weeks (date of injury
2007) and 47 years (date of injury 1960). At the time of
examination, 12 patients received spasmolytic medication
(Baclofen tablets, Baclofen pump, benzodiazepines, can-
nabis, or Botox injections, Table 1).
Clinical examinations
The clinical examinations were performed based on a
standard protocol when patients came to the paraplegia
center for a regular check-up or at least one month after
they had been hospitalized after trauma. Examinations
were conducted over two years (2006–2008) by the same
examiner. To test for the BS, mechanical stimuli were
applied by the smooth, blunt handle of a reflex hammer
(0 = absent, 1 = present). According to the recommen-
dations of Dohrmann et al. [7] the lateral plantar surface
was repeatedly stroked in a slow movement lasting 5–6 s
from the heel to up to the middle metatarsophalangeal
joint. Patella and Achilles tendon tap reflexes were taken
for evaluation of lower limb reflex excitability in all
patients (0 = no elicitable reflex, 1 = weak, 2 = nor-
mal, 3 = exaggerated reflex). In tetraplegic subjects,
biceps reflex, triceps reflex and brachioradialis reflex
were also tested. Muscle tone of upper (only tetraplegic
patients) and lower limbs was assessed according to the
Modified Ashworth Scale (MAS 0, flaccid muscle tone,
to 4, limb rigid in flexion or extension). Reflex status
and muscle tone were also repeatedly assessed in one
tetraplegic subject who received three intrathecal injec-
tions with Baclofen (50, 75 and 100 lg) for therapeutic
reasons.
Electrophysiological recordings
In all patients lacking a BS, electrophysiological exami-
nation of the common peroneal nerve was performed in
order to demonstrate integrity of these motor units.
Examinations were conducted over two years (2006–2008)
by the same examiner. Compound muscle action potentials
and nerve conduction velocity were measured. In subjects
with abnormal neurography (cMAP obtained from peroneal
nerve\1.0 mV), needle recordings (EMG) were performed
in the M. extensor hallucis longus (Table 2). Ratings were
as follows: no peripheral damage, acute denervation,
chronic neuropathy, complete denervation, not testable.
For subjects with an injury date after the year 2000,
completeness of SCI was additionally confirmed by a lack
of tibial nerve evoked somatosensory potential (tSSEP)
(pre-existing data). Before the year 2000, tSSEP was not
part of the standard assessments of the conducting center.
Statistics
Mann–Whitney Test was used to relate the following
clinical parameters: BS, level of lesion, subject age, dura-
tion of SCI, age at onset of SCI, spasmolytic medication,
reflex excitability, and the maximum MAS score of each
subject. Reflexes were assumed to be exaggerated if at
least one reflex in arms and legs (cervical lesions) or in the
legs was exaggerated (Table 1). A significant result was
assumed if P \ 0.05.
Results
A total of 17 (49%) out of the 35 traumatic complete SCI
subjects examined presented with a positive BS while this
was absent in 18 patients (51%). In three cases, the BS was
only elicitible in one leg while in 13 it appeared bilaterally.
In two patients (No. 10 and 22, Table 1) only one leg could
be examined because the patients wore a leg cast. One of
them presented with a positive BS, the other one with a
negative sign. Eight patients with a positive BS and four
patients with a negative BS were under some spasmolytic
medication (Table 1). The neurographic and EMG exam-
inations of the peroneal nerve were conducted in 14 out of
18 patients with a negative Babinksi sign (Table 2). Three
patients showed no peripheral nerve lesion, while in 11
patients (22 legs) bilateral peripheral nerve damage could
be demonstrated. Acute denervation was found in eight
legs. Chronic neuropathy could be demonstrated in six
legs. Complete denervation could be proven in eight legs.
In four subjects, the electrophysiological examination
could not be performed due to death (No. 15), unwilling-
ness to participate (No. 3), move to a foreign country
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(No. 1) or because the patient did not respond. In 14 out of
35 subjects, clinically complete SCI had previously been
confirmed by the lack of tibial somatosensory potentials.
Muscle tone was increased (MAS 1–4) in 24 (67%) of
all patients examined in this study. This was the case in
all but one subject with a positive BS (16 of 17, 94%).
Figure 1 shows that subjects with a positive BS tend to
have high levels of MAS while in those without a BS
muscle tone is rather low. Tendon tap reflexes were
exaggerated in 14 subjects (40%). Ten of these subjects had
a positive BS, while in four of the patients a BS was absent.
The relationship between a positive BS and increased
muscle tone (MAS) was highly significant (Z = -3.669;
P \ 0.001), while the relationship with tendon reflex
Table 1 Clinical data of subjects included in the study
No. Sex Age,
years
Level Examination
(months after
SCI)
Medication Babinski
right
Babinski
left
Maximum
MAS
Exaggerated reflexes
1 M 41 C5 102 0 0 1 None
2 M 37 C6 201 0 0 1 AR ri, AR le
3 M 56 C7 276 0 0 0 AR ri, AR le
4 F 58 C4 13 Baclofen pump 1 0 3 None
5 M 19 C4 2 Baclofen 3 9 5 mg/day 1 1 2 None
6 F 65 C5 23 1 1 1 None
7 M 27 C6 62 1 1 2 PR ri, PR le, AR ri, AR le, BR li, BR
re, TR ri, TR le, BRR ri, BRR le
8 M 36 C7 424 Clonazepam 2 9 2 mg/
day
1 1 3 PR ri, PR le, AR ri, AR le, BR ri, BR
le, TR ri, TR le, BRR ri, BRR le
9 M 29 C7 104 1 1 3 PR ri, PR le, AR ri, AR le, BR ri, BR
le, TR ri, TR le, BRR ri, BRR le
10 M 67 C8 567 1 NT 0 None
11 M 29 T10 1 0 0 0 None
12 F 75 T11 471 0 0 0 None
13 M 27 T11 116 0 0 0 None
14 M 25 T11 91 0 0 0 None
15 M 55 T12 343 0 0 0 None
16 M 52 T2 396 0 0 0 None
17 M 40 T2 13 0 0 0 PR ri, PR le, AR ri, AR le,
18 M 41 T3 5 0 0 1 None
19 M 43 T4 222 Occasionally cannabis 0 0 3 None
20 M 85 T4 401 Baclofen 3 9 25 mg/day 0 0 1 None
21 M 56 T4 6 Baclofen 2 9 10 mg/day 0 0 1 None
22 M 59 T5 315 0 NT 0 None
23 M 45 T5 281 Baclofen 5 9 25 mg/day;
Clonazepam 2 9 2 mg/
day
0 0 0 PR ri, PR le
24 M 42 T6 182 0 0 3 None
25 M 44 T7 117 0 0 1 None
26 M 43 T10 235 Diazepam 1 9 10 mg/day 1 1 3 PR ri, PR le, AR ri, AR le
27 F 20 T10 83 Botox 300 IE Botox in
lower extremities
1 1 1 None
28 F 83 T11 20 1 1 2 PR ri, PR le, AR ri, AR le
29 M 23 T11 13 1 1 2 None
30 M 44 T2 13 Baclofen 4 9 25 mg/day 1 1 3 PR ri, PR le, AR ri, AR le
31 M 37 T4 185 1 0 3 PR ri, PR le, AR ri, AR le
32 M 70 T5 29 Baclofen 1 9 50 mg/day 1 1 3 None
33 M 35 T7 170 1 1 3 PR ri, PR le
34 M 39 T7 3 0 1 2 PR ri, PR le
35 M 33 T9 88 Baclofen 7 9 25 mg/day 1 1 1 PR ri, PR le, AR ri
NT Not testable (leg cast), PR Patellar reflex, AR Achilles reflex, BR biceps reflex, BRR brachioradialis reflex, TR triceps reflex, ri right, le left
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excitability was at the border of significance (Z = -2.177;
P = 0.067) (Table 1). Testing for an association between
reflex exaggeration and MAS also yielded a trend that both
were related (Z = -2.010; P = 0.053).
Levels of lesion ranged from C5 to T12 in the group
with a negative BS and from C4 to T11 in the group with a
positive BS with an almost symmetric distribution of lesion
levels in both groups. Average duration of SCI was 9.3
(0.5–47.7) years for patients with a positive BS, and 16.9
(0–39.4) years for patients with a negative BS. The BS did
not show a significant relationship with any of the fol-
lowing data: level of lesion, subject age, duration of SCI,
age at onset of SCI, and spasmolytic medication.
Baclofen injection
One subject received three therapeutic injections of 50, 75
and 100 lg of Baclofen on three consecutive days. Before
each injection, it was clinically confirmed that the patient
had increased muscle tone in the lower legs (up to MAS 3)
and a positive BS bilaterally. Four hours after the first
injection (50 lg), muscle tone was low (MAS 1) and the
BS was present unilaterally. Four hours after the second
injection (75 lg), muscle tone was low (MAS 0–1) and the
BS was bilaterally absent. Four hours after the third
injection (100 lg), muscle tone was flaccid (MAS 0) and
the BS was absent bilaterally. Twenty-four hours later, the
BS reappeared.
Discussion
Four principal features emerged from this case study on the
occurrence of a BS in SCI. First, the Babinksi sign may or
Fig. 1 Degree of muscle tone in lower extremities according to the
Modified Ashworth Scale (MAS) in 35 SCI subjects with absent or
present Babinski signs. Maximum MAS = highest muscle tone from
upper and lower (tetraplegic) or lower (paraplegic) extremities
according to the MAS
Table 2 Patients with a negative Babinski sign: electrophysiological data (peroneal nerve)
No. Cmap ri
(mV)
NCV ri
(m/s)
Cmap le
(mV)
NCV le
(m/s)
sA
EHL ri
sA
EHL le
Needle
potential
EHL ri
Needle
potential
EHL le
Damage ri Damage le
1 NT NT NT NT NT NT NT NT
2 0.00 1.70 4/10 4/10 2.00 2.60 Acute denervation Acute denervation
3 NT NT NT NT NT NT NT NT
11 1.20 1.10 ND ND ND ND None None
12 0.00 0.00 0.00 0.00 0/10 0/10 ND ND Chronic neuropathy Chronic neuropathy
13 0.00 0.00 ND 3/10 0.00 0.00 Complete denervation Complete denervation
14 NT NT NT NT NT NT NT NT
15 NT NT NT NT NT NT NT NT
16 0.00 0.00 0/10 4/10 3.90 1.60 Chronic neuropathy Acute denervation
17 7.80 58.60 6.50 54.60 ND ND ND ND None None
18 0.20 0.00 8/10 3/10 2.80 0.00 Acute denervation Complete denervation
19 0.00 0.00 0/10 0/10 0.00 0.00 Complete denervation Complete denervation
20 0.00 0.00 4/10 4/10 0.00 1.20 Complete denervation Acute denervation
21 0.00 0.00 6/10 7/10 1.10 1.50 Acute denervation Acute denervation
22 0.60 0.10 2/10 2/10 3.50 1.10 Chronic neuropathy Chronic neuropathy
23 0.00 0.00 5/10 3/10 1.00 0.00 Acute denervation Complete denervation
24 0.00 0.00 1/10 1/10 0.00 1.20 Complete denervation Chronic neuropathy
25 2.90 42.50 3.90 49.30 ND ND ND ND None None
NT Not testable, ND not done, Cmap compound muscle action potential, NCV nerve conduction velocity, sA spontaneous activity, EHL M.
extensor hallucis longus, ri right, le left
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may not be present in complete SCI subjects. Secondly,
there seems to be a close association between the
occurrence of the BS and increased muscle tone. Third,
the BS is depressed and muscle tone reduced by intra-
thecal injection of Baclofen [16]. Therefore, muscle tone
seems to be a requirement for the occurrence of the BS.
Fourth, the absence of the BS is otherwise most likely due
to peripheral nerve damage if not explained by low
muscle tone.
In the present study it is unlikely that the co-occurrence
of a lacking BS and reduced muscle tone is due to a pro-
tracted spinal shock, defined by flaccid muscle paresis and
loss of tendon reflexes below the level of lesion [4]. Spinal
shock has been reported to end 1–3 days [6] to a few weeks
post-injury. The BS is usually present within 2 weeks after
SCI [12] and its absence in the initial phase is probably due
to a temporary suppression of interneuronal activity [15].
In our study, duration of SCI and presence of the BS
were not interrelated, i.e. 30 of the tested subjects were in
the chronic stage of SCI while five subjects were injured
1–6 months prior to examination. In these latter cases, the
lack of the BS might be due to a persistence of spinal shock
(patients number 5, 11, 18, 21, 34, Table 1). However, 15
of the 30 chronic patients were also lacking a BS and thus
the lack cannot be attributed to spinal shock.
In most of our SCI subjects the absence of the BS was
associated with a peripheral neuropathy. This is in line with
earlier reports indicating that an absence of the BS is fre-
quently due to damage to the segmental reflex pathway.
[19] It is known that peripheral nerve function is often
abnormal in the lower limb in patients with cervical
lesions. Specifically, CMAP in the tibial and peroneal
nerves are often reduced and motor conduction velocity is
slow [11]. A possible explanation might be a transsynaptic
peripheral degeneration of alpha motoneurons in the con-
text of SCI [11, 14], which occurs when motoneurons are
deprived of supraspinal trophic inputs. Additionally,
peripheral nerve damage in chronic SCI subjects might be
due to neuropathy or pressure palsy which in this popula-
tion is more likely to occur due to immobility and wheel-
chair use. The latter possibility however seems rather
unlikely in the subjects presented here since in all cases,
peripheral nerve damage was observed bilaterally. Axonal
motor neuropathy was also observed in conus or cauda
damage [3]. However, conus and cauda lesions as well as
lumbar lesions had been excluded from this study
beforehand.
From the present data it cannot however be excluded
that some of our chronic patients had a positive BS before
developing a motor neuropathy or transsynaptic neuronal
degeneration.
Interestingly, there seems to be only a weak relationship
between the BS and tendon tap reflex excitability.
Consequently the BS and exaggerated tendon reflexes are
not necessarily conjoint signs of a pyramidal tract lesion
[18]. Correspondingly, a stronger positive relationship
between the occurrence of a BS and increased muscle tone
is in line with the observation of a discrepancy between
clinical signs of spasticity and spastic movement disorders
[5]. This may be attributed to the different roles of reflexes
in passive and active movement conditions. In line with
this, it is known that recovery from spinal shock is char-
acterised by mono- and poly-synaptic reflex activity reap-
pearing at different time points after SCI [9, 12]. This indicates
that different mechanisms are responsible for either phe-
nomenon, while pathophysiologically, both reflex activity and
muscle tone are part of the spastic syndrome [4].
In conclusion, there exists an association of the BS and
increased muscle tone, which may depend on a combina-
tion of altered spinal interneuronal activity and changes in
muscle mechanics [5]. On the one hand, this can also be
suggested since the BS disappears after the intrathecal
application of Baclofen. By this route of administration,
Baclofen concentrations at the spinal level reach four times
the local concentration reached in the spinal cord after a
typical oral dose [10]. On the other hand, the presence of
peripheral neuropathy will also contribute to decreased
muscle tone and thus can explain the interrelation of the
occurrence of a BS and the level of muscle tone.
Our findings support the notion that there is no rela-
tionship between a particular anatomical lesion site in the
cortico-spinal tract and the presence of a BS [17]. Roughly
half of the patients with complete SCI in our study did not
show a BS or increased muscle tone. This was the case
even though a damaged pyramidal tract was assumed to
exist in the SCI subjects according to clinical and elec-
trophysiological data. Therefore, it is concluded that the
presence of a BS in SCI subjects does not primarily depend
on the damage of a specific spinal level or on the pathways
projecting onto the interneuronal zone of the lumbosacral
cord [18] or of direct cortico-spinal projections [8, 13].
Furthermore, it must be assumed that a minimal muscle
tone is required to allow for the presence of a BS.
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